All Biotech News

List of articles in category All Biotech News
Title	Published Date
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany	06/06/2024
Atriva Therapeutics Secures US Patent for MEK Inhibitor Zapnometinib (ATR-002), a First-in-Class Broad Spectrum Therapy for Severe RNA Virus Infections Including Bird Flu (H5N1)	06/06/2024
Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor	06/05/2024
Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters	06/04/2024
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development	05/29/2024
Vetter Wins Best Managed Companies Award 2024	05/28/2024
New CRO Focused on Cannabis-based Drug Trials Launched	05/22/2024
Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA	05/16/2024
NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery	05/14/2024
Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification	05/13/2024
Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template	05/09/2024
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023	05/08/2024
Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells	05/08/2024
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.	05/08/2024
Change in Management	04/30/2024
Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory	04/25/2024
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery	04/09/2024
Osteolabs to Present New Clinical Data from Over 2.400 OsteoTest Routine Samples at the WCO-IOF-ESCEO Congress	04/09/2024
Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article	04/09/2024
Celonic Launches New GS-CHOvolution® Cell Line Expression System	04/08/2024
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study	04/03/2024
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research	04/03/2024
Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence	03/28/2024
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever	03/27/2024
ProteoNic Unveils Early Access Program, Elevating Viral Vector Titers with Transformative LV-2G UNic® Technology	03/27/2024
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards	03/26/2024
Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors	03/21/2024
Single Use Support Opens US Office	03/14/2024
Viroclinics-DDL Changes Name to Cerba Research	03/14/2024
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology	03/13/2024

Page 10 of 88